Search Results - "Ten Brinke, Anneke"

Alpine altitude climate treatment for severe and uncontrolled asthma: An EAACI position paper by Fieten, Karin B., Drijver‐Messelink, Marieke T., Cogo, Annalisa, Charpin, Denis, Sokolowska, Milena, Agache, Ioana, Taborda‐Barata, Luís Manuel, Eguiluz‐Gracia, Ibon, Braunstahl, Gerrit J., Seys, Sven F., den Berge, Maarten, Bloch, Konrad E., Ulrich, Silvia, Cardoso‐Vigueros, Carlos, Kappen, Jasper H., Brinke, Anneke ten, Koch, Markus, Traidl‐Hoffmann, Claudia, da Mata, Pedro, Prins, David J., Pasmans, Suzanne G. M. A., Bendien, Sarah, Rukhadze, Maia, Shamji, Mohamed H., Couto, Mariana, Oude Elberink, Hanneke, Peroni, Diego G., Piacentini, Giorgio, Weersink, Els J. M., Bonini, Matteo, Rijssenbeek‐Nouwens, Lucia H. M., Akdis, Cezmi A.

“…Currently available European Alpine Altitude Climate Treatment (AACT) programs combine the physical characteristics of altitude with the avoidance of…”
Get full text

Systematic Assessment of Difficult-to-Treat Asthma: Principles and Perspectives by Hew, Mark, Menzies-Gow, Andrew, Hull, James H., Fleming, Louise, Porsbjerg, Celeste, Brinke, Anneke Ten, Allen, David, Gore, Robin, Tay, Tunn Ren

“…Difficult-to-treat asthma affects a minority of adults and children with asthma but represents a challenging mix of misdiagnosis, multimorbidity, inadequate…”
Get full text

Management of the patient with eosinophilic asthma: a new era begins by de Groot, Jantina C, Ten Brinke, Anneke, Bel, Elisabeth H D

“…Now that it is generally accepted that asthma is a heterogeneous condition, phenotyping of asthma patients has become a mandatory part of the diagnostic workup…”
Get full text

Clinical profile of patients with adult-onset eosinophilic asthma by de Groot, Jantina C, Storm, Huib, Amelink, Marijke, de Nijs, Selma B, Eichhorn, Edwin, Reitsma, Bennie H, Bel, Elisabeth H D, Ten Brinke, Anneke

“…Adult-onset eosinophilic asthma is increasingly recognised as a severe and difficult-to-treat subtype of asthma. In clinical practice, early recognition of…”
Get full text

"Refractory" Eosinophilic Airway Inflammation in Severe Asthma: Effect of Parenteral Corticosteroids by ten Brinke, Anneke, Zwinderman, Aeilko H, Sterk, Peter J, Rabe, Klaus F, Bel, Elisabeth H

“…It has been suggested that patients with refractory eosinophilic airway inflammation represent a separate "eosinophilic" asthma phenotype associated with…”
Get full text

Consistency of sputum eosinophilia in difficult-to-treat asthma: A 5-year follow-up study by van Veen, Ilonka H., MD, ten Brinke, Anneke, MD, PhD, Gauw, Stefanie A, Sterk, Peter J., MD, PhD, Rabe, Klaus F., MD, PhD, Bel, Elisabeth H., MD, PhD

“…Characteristics of patients and methods are described elsewhere in detail.3,6,7 In 1998 and 1999 (visit 1), patient characteristics (sex, age, atopic status,…”
Get full text

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response by Leckie, Margaret J, Brinke, Anneke ten, Khan, Jamey, Diamant, Zuzana, O'Connor, Brian J, Walls, Christine M, Mathur, Ashwini K, Cowley, Hugh C, Chung, K Fan, Djukanovic, Ratko, Hansel, Trevor T, Holgate, Stephen T, Sterk, Peter J, Barnes, Peter J

“…Interleukin-5 (IL-5) is essential for the formation of eosinophils, which are thought to have a major role in the pathogenesis of asthma and other allergic…”
Get full text

Clinical response to benralizumab can be predicted by combining clinical outcomes at 3 months with baseline characteristics by Kroes, Johannes A, de Jong, Kim, Hashimoto, Simone, Zielhuis, Sander W, van Roon, Eric N, Sont, Jacob K, Ten Brinke, Anneke

“…Benralizumab is highly effective in many, but not all, patients with severe asthma. Baseline characteristics alone are insufficient to predict an individual's…”
Get full text

Treatment Eligibility of Real-Life Mepolizumab-Treated Severe Asthma Patients by Richards, Levi B., van Bragt, Job J.M.H., Aarab, Reim, Longo, Cristina, Neerincx, Anne H., Sont, Jaap K., Weersink, Els J.M., Braunstahl, Gert-Jan, Brinke, Anneke Ten, Bel, Elisabeth H.D., Maitland-van der Zee, Anke-Hilse

“…Patients with severe asthma not meeting the strict trial eligibility criteria for mepolizumab are now routinely treated with this biological in clinical…”
Get full text

What bothers severe asthma patients most? A paired patient-clinician study across seven European countries by Ainsworth, Ben, Chatburn, Eleanor, Bansal, Aruna T, Fulton, Olivia, Hamerlijnck, Dominique, Coleman, Courtney, Eger, Katrien, Hyland, Michael, Holmes, Joshua, Heaney, Liam, Sedlák, Vratislav, Škrgat, Sabina, Edelbaher, Natalija, Ten Brinke, Anneke, Porsbjerg, Celeste, Gaga, Mina, Loureiro, Claudia, Djukanovic, Ratko, Berret, Emmanuelle, Kwon, Namhee

“…Severe asthma is a complex, multidimensional disease. Optimal treatment, adherence and outcomes require shared decision-making, rooted in mutual understanding…”
Get full text

Severe adult-onset asthma: A distinct phenotype by Amelink, Marijke, MD, de Groot, Jantina C., MD, de Nijs, Selma B., MSc, Lutter, Rene, PhD, Zwinderman, Aeilko H., PhD, Sterk, Peter J., MD, PhD, ten Brinke, Anneke, MD, PhD, Bel, Elisabeth H., MD, PhD

“…Background Some patients with adult-onset asthma have severe disease, whereas others have mild transient disease. It is currently unknown whether patients with…”
Get full text

Blueprint for harmonising unstandardised disease registries to allow federated data analysis: prepare for the future by Kroes, Johannes A., Bansal, Aruna T., Berret, Emmanuelle, Christian, Nils, Kremer, Andreas, Alloni, Anna, Gabetta, Matteo, Marshall, Chris, Wagers, Scott, Djukanovic, Ratko, Porsbjerg, Celeste, Hamerlijnck, Dominique, Fulton, Olivia, ten Brinke, Anneke, Bel, Elisabeth H., Sont, Jacob K.

“…Real-world evidence from multinational disease registries is becoming increasingly important not only for confirming the results of randomised controlled…”
Get full text

SHARP: enabling generation of real-world evidence on a pan-European scale to improve the lives of individuals with severe asthma by van Bragt, Job J M H, Hansen, Susanne, Djukanovic, Ratko, Bel, Elisabeth H D, Ten Brinke, Anneke, Wagers, Scott S, Maitland-van der Zee, Anke H, Porsbjerg, Celeste

“…Real-world evidence is important to help unravel unanswered problems in severe asthma and is valuable to better understand the patient experience and common…”
Get full text

Characteristics of severe asthma patients on biologics: a real-life European registry study by Principe, Stefania, Richards, Levi B, Hashimoto, Simone, Kroes, Johannes Anthon, Van Bragt, Job J M H, Vijverberg, Susanne J, Sont, Jacob K, Scichilone, Nicola, Bieksiene, Kristina, Ten Brinke, Anneke, Csoma, Zsuzsanna, Dahlén, Barbro, Gemicioglu, Bilun, Grisle, Ineta, Kuna, Piotr, Lazic, Zorica, Mihaltan, Florin, Popović-Grle, Sanja, Škrgat, Sabina, Marcon, Alessandro, Caminati, Marco, Djukanovic, Ratko, Porsbjerg, Celeste, Maitland Van Der Zee, Anke-Hilse

“…The use of anti-interleukin-5 (IL5) for severe asthma is based on criteria from randomised controlled trials (RCTs), but in real-life patients might not fulfil…”
Get full text

Long-Term Therapy Response to Anti–IL-5 Biologics in Severe Asthma—A Real-Life Evaluation by Eger, Katrien, Kroes, Johannes A., ten Brinke, Anneke, Bel, Elisabeth H.

“…Patients with severe eosinophilic asthma show different responses to various anti–IL-5 biologics, ranging from super response to nonresponse. Residual disease…”
Get full text

Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial by Chupp, Geoffrey L, Prof, Bradford, Eric S, MD, Albers, Frank C, MD, Bratton, Daniel J, PhD, Wang-Jairaj, Jie, MD, Nelsen, Linda M, MHS, Trevor, Jennifer L, MD, Magnan, Antoine, Prof, ten Brinke, Anneke, MD

“…Summary Background Mepolizumab, an anti-interleukin-5 monoclonal antibody approved as add-on therapy to standard of care for patients with severe eosinophilic…”
Get full text

Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy by Eger, Katrien, Hashimoto, Simone, Braunstahl, Gert Jan, Brinke, Anneke ten, Patberg, Kornelis W., Beukert, Annelies, Smeenk, Frank, van der Sar–van der Brugge, Simone, Weersink, Els J.M., Bel, Elisabeth H.

“…It is unclear whether asthma and asthma medications increase or decrease the risk of severe COVID-19, and this is particularly true for patients with severe…”
Get full text

Reply to “Impact of oral corticosteroid on long-term weight following initiation of anti-IL-5/5Ra biologics in severe asthma” by ten Have, Lianne, de Jong, Kim, ten Brinke, Anneke

Get full text

Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes by Westerhof, Guus A, Korevaar, Daniël A, Amelink, Marijke, de Nijs, Selma B, de Groot, Jantina C, Wang, Junfeng, Weersink, Els J, ten Brinke, Anneke, Bossuyt, Patrick M, Bel, Elisabeth H

“…Several biomarkers have been used to assess sputum eosinophilia in asthma. It has been suggested that the diagnostic accuracy of these biomarkers might differ…”
Get full text

Targeting dynamic hyperinflation in moderate-to-severe asthma: a randomised controlled trial by van der Meer, Akke-Nynke, de Jong, Kim, Hoekstra-Kuik, Aranka, Bel, Elisabeth H., ten Brinke, Anneke

“…Background Dynamic hyperinflation is highly prevalent in moderate-to-severe asthma, which may significantly impede activities of daily life. We hypothesised…”
Get full text